Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5290539
Max Phase: Preclinical
Molecular Formula: C32H43N7O6
Molecular Weight: 621.74
Associated Items:
ID: ALA5290539
Max Phase: Preclinical
Molecular Formula: C32H43N7O6
Molecular Weight: 621.74
Associated Items:
Canonical SMILES: CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(N)=O)[C@@H](C)O
Standard InChI: InChI=1S/C32H43N7O6/c1-19(40)28(29(34)42)39-30(43)25(14-8-9-15-33)37-32(45)27(17-22-18-35-24-13-7-6-12-23(22)24)38-31(44)26(36-20(2)41)16-21-10-4-3-5-11-21/h3-7,10-13,18-19,25-28,35,40H,8-9,14-17,33H2,1-2H3,(H2,34,42)(H,36,41)(H,37,45)(H,38,44)(H,39,43)/t19-,25+,26+,27+,28+/m1/s1
Standard InChI Key: OHTCHFUKVDURAI-MMDZAOKXSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 621.74 | Molecular Weight (Monoisotopic): 621.3275 | AlogP: -0.09 | #Rotatable Bonds: 17 |
Polar Surface Area: 221.53 | Molecular Species: BASE | HBA: 7 | HBD: 8 |
#RO5 Violations: 2 | HBA (Lipinski): 13 | HBD (Lipinski): 10 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.71 | CX Basic pKa: 24.99 | CX LogP: -0.65 | CX LogD: -3.13 |
Aromatic Rings: 3 | Heavy Atoms: 45 | QED Weighted: 0.10 | Np Likeness Score: 0.11 |
1. Van der Poorten O, Knuhtsen A, Sejer Pedersen D, Ballet S, Tourwé D.. (2016) Side Chain Cyclized Aromatic Amino Acids: Great Tools as Local Constraints in Peptide and Peptidomimetic Design., 59 (24): [PMID:27690430] [10.1021/acs.jmedchem.6b01029] |
Source(1):